医疗器械公司Ceribell宣布，其用于大血管闭塞（LVO）卒中检测与监测的创新型解决方案，已获得美国食品药品监督管理局（FDA）颁发的突破性器械认定。这一认定旨在加速该产品的开发和审评进程，为亟需先进诊断工具的重症患者带来希望。
医疗器械公司Ceribell宣布，其用于大血管闭塞（LVO）卒中检测与监测的创新型解决方案，已获得美国食品药品监督管理局（FDA）颁发的突破性器械认定。这一认定旨在加速该产品的开发和审评进程，为亟需先进诊断工具的重症患者带来希望。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.